"Your cardiovascular health is our top priority. Our extensive team of physicians and healthcare professionals is dedicated to providing compassionate expert care as quickly and efficiently as possible."

During the past decade, Wellmont CVA Heart Institute conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 21 clinical trials were completed, i.e. on average, 91.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 15 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wellmont CVA Heart Institute" #1 sponsor was "C. R. Bard" with 5 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Endologix" with 3 trials sponsored and "Alucent Biomedical" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellmont CVA Heart Institute" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Wellmont CVA Heart Institute" are "Coronary Artery Disease" (5 trials), "Peripheral Arterial Disease" (5 trials), "Femoral Artery Occlusion" (3 trials), "Femoral Artery Stenosis" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Wellmont CVA Heart Institute" in a lesser frequency.

Most popular intervention types in "Wellmont CVA Heart Institute" are "Device" (33 trials), "Drug" (5 trials), "Combination Product" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lutonix DCB" (2 trials), "Lutonix Drug Coated Balloon" (2 trials), "NVS Therapy" (2 trials), "99mTechnicium (sestamibi or tetrofosmin)" (1 trials) and "Alto Abdominal Stent Graft System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wellmont CVA Heart Institute" are 41 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wellmont CVA Heart Institute". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Wellmont CVA Heart Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wellmont CVA Heart Institute, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 25 trials that are defined as “Not Applicable".